Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

JenaValve announced today that it received the green light to begin a new randomized controlled trial for its Trilogy device.

The ACCESS-TAVI trial demonstrated that a combined suture/plug-based vascular closure device strategy significantly reduces ...

FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...